SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:SVS - IT0005469264 - Common Stock
7.88 EUR
-0.46 (-5.52%)
Taking everything into account, SVS scores 5 out of 10 in our fundamental rating. SVS was compared to 62 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SVS while its profitability can be described as average. SVS is growing strongly while it also seems undervalued. This is an interesting combination
1. Profitability
1.1 Basic Checks
SVS had positive earnings in the past year.
SVS had a negative operating cash flow in the past year.
In the past 5 years SVS has always been profitable.
In the past 5 years SVS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of SVS (3.75%) is comparable to the rest of the industry.
SVS's Return On Equity of 10.43% is fine compared to the rest of the industry. SVS outperforms 67.74% of its industry peers.
With a decent Return On Invested Capital value of 8.04%, SVS is doing good in the industry, outperforming 69.35% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SVS is below the industry average of 9.74%.
The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROIC | 8.04% |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
1.3 Margins
SVS has a Profit Margin (5.09%) which is comparable to the rest of the industry.
SVS's Profit Margin has improved in the last couple of years.
SVS's Operating Margin of 8.71% is in line compared to the rest of the industry. SVS outperforms 48.39% of its industry peers.
SVS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 26.17%, SVS is doing worse than 85.48% of the companies in the same industry.
SVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% |
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
2. Health
2.1 Basic Checks
SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SVS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SVS has been reduced compared to 5 years ago.
SVS has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.79, we must say that SVS is in the distress zone and has some risk of bankruptcy.
SVS has a worse Altman-Z score (1.79) than 61.29% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that SVS is somewhat dependend on debt financing.
SVS's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. SVS is outperformed by 69.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.79 |
ROIC/WACC1.16
WACC6.92%
2.3 Liquidity
A Current Ratio of 1.82 indicates that SVS should not have too much problems paying its short term obligations.
SVS has a Current ratio (1.82) which is in line with its industry peers.
A Quick Ratio of 1.34 indicates that SVS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.34, SVS is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
SVS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.97% yearly.
The Revenue has grown by 9.07% in the past year. This is quite good.
Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 10.34% on average per year.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
3.2 Future
The Earnings Per Share is expected to grow by 14.83% on average over the next years. This is quite good.
SVS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.07% yearly.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.20, the valuation of SVS can be described as very cheap.
Based on the Price/Earnings ratio, SVS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.84, SVS is valued rather cheaply.
A Price/Forward Earnings ratio of 5.34 indicates a rather cheap valuation of SVS.
SVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. SVS is cheaper than 96.77% of the companies in the same industry.
SVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.2 | ||
| Fwd PE | 5.34 |
4.2 Price Multiples
SVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SVS is cheaper than 91.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.45 |
4.3 Compensation for Growth
SVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS's earnings are expected to grow with 14.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)0.31
EPS Next 2Y17.92%
EPS Next 3Y14.83%
5. Dividend
5.1 Amount
SVS has a Yearly Dividend Yield of 3.17%.
SVS's Dividend Yield is rather good when compared to the industry average which is at 1.11. SVS pays more dividend than 90.32% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, SVS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.17% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SVS pays out 19.64% of its income as dividend. This is a sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
BIT:SVS (12/23/2025, 7:00:00 PM)
7.88
-0.46 (-5.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.66%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.13M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target15.05 (90.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.17% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.2 | ||
| Fwd PE | 5.34 | ||
| P/S | 0.33 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.68 | ||
| P/tB | 0.94 | ||
| EV/EBITDA | 4.45 |
EPS(TTM)1.27
EY16.12%
EPS(NY)1.47
Fwd EY18.71%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.19
PEG (5Y)0.31
Graham Number18.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROCE | 10.81% | ||
| ROIC | 8.04% | ||
| ROICexc | 10.91% | ||
| ROICexgc | 14.1% | ||
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% | ||
| FCFM | N/A |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.36 | ||
| Cap/Depr | 113.41% | ||
| Cap/Sales | 4.68% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.79 |
F-Score5
WACC6.92%
ROIC/WACC1.16
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%
SVAS BIOSANA SPA / SVS.MI FAQ
What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to SVS.MI.
What is the valuation status of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.
How profitable is SVAS BIOSANA SPA (SVS.MI) stock?
SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.
How financially healthy is SVAS BIOSANA SPA?
The financial health rating of SVAS BIOSANA SPA (SVS.MI) is 3 / 10.
How sustainable is the dividend of SVAS BIOSANA SPA (SVS.MI) stock?
The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 6 / 10 and the dividend payout ratio is 19.64%.